mdl 74156 has been researched along with gr 65630 in 1 studies
| Studies (mdl 74156) | Trials (mdl 74156) | Recent Studies (post-2010) (mdl 74156) | Studies (gr 65630) | Trials (gr 65630) | Recent Studies (post-2010) (gr 65630) |
|---|---|---|---|---|---|
| 14 | 5 | 2 | 57 | 0 | 4 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baron, BM; Boeijinga, PH; Dudley, MW; Galvan, M; Siegel, BW; Slone, AL | 1 |
1 other study(ies) available for mdl 74156 and gr 65630
| Article | Year |
|---|---|
Characterization of the novel 5-HT3 antagonists MDL 73147EF (dolasetron mesilate) and MDL 74156 in NG108-15 neuroblastoma x glioma cells.
Topics: Animals; Binding, Competitive; Glioma; Hybrid Cells; Imidazoles; Indoles; Membrane Potentials; Mice; Neuroblastoma; Quinolizines; Rats; Receptors, Serotonin; Serotonin Antagonists | 1992 |